Drawing for EZOLVEN

USPTO serial 98103295

EZOLVEN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DUONG, ANGELA GAW
Law office
TMO LAW OFFICE 130

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EZOLVEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wisu Sul

450 Elanco CircleIndianapolis, IN 46221United States

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment, diagnosis, prevention and control of infectious diseases in food producing animals and livestock; veterinary preparations for enhancing reproduction in livestock; immunorestorative biopharmaceuticals for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; animal feed additives for use as nutritional supplements; veterinary preparations or animal feed additives for use in decreasing gas emissions from animals, animal carcasses, or animal waste; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparations in the nature of biological implants for animals, namely, progesterone, estrogen and testosterone; veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat; veterinary preparations for companion animals, namely, to treat and prevent parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders; veterinary preparations for companion animals for nonsurgical sterilization, namely, hormones for the control and prevention of reproductive functions; veterinary preparations for treating and preventing fleas, ticks, lice, flies, and mosquitos on companion animals; veterinary preparations, namely, vaccines for companion animals including horses; veterinary preparations to control diseases and parasites in fishACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 17, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 17, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 19, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 19, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 19, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 19, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 19, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 19, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2025EX3GSOU EXTENSION 3 GRANTED—
Dec 17, 2025EXT3SOU EXTENSION 3 FILED—
Dec 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 26, 2025EX2GSOU EXTENSION 2 GRANTED—
Jun 26, 2025EXT2SOU EXTENSION 2 FILED—
Jun 26, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 15, 2025EX1GSOU EXTENSION 1 GRANTED—
Jan 14, 2025EXT1SOU EXTENSION 1 FILED—
Jan 14, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 16, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 21, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Apr 15, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 15, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 15, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 28, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2024DOCKASSIGNED TO EXAMINER—
Aug 1, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance